Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer in Men With a High Baseline International Prostate Symptom Score (IPSS ≥ 15)-Reference-Cited by-同舟云学术

Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer in Men With a High Baseline International Prostate Symptom Score (IPSS ≥ 15)

Published:2020-07-03 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Aghdam Nima,Pepin Abigail,Buchberger David,Hirshberg Jason,Lei Siyuan,Ayoob Marilyn,Danner Malika,Yung Thomas,Kumar Deepak,Collins Brian T.,Lynch John,Kataria Shaan,Suy Simeng,Collins Sean P.

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference52 articles.

1. Stereotactic body radiation therapy (SBRT) for prostate cancer in men with a high international prostate symptom score (IPSS > 15);Kataria;Int J Radiat Oncol Biol Phys,2017

2. External beam radiotherapy for prostate cancer: urinary outcomes for men with high international prostate symptom scores (IPSS);Malik;Int J Radiat Oncol Biol Phys,2011

3. Patterns and predictors of amelioration of genitourinary toxicity after high-dose intensity-modulated radiation therapy for localized prostate cancer: implications for defining postradiotherapy urinary toxicity;Ghadjar;Eur Urol,2013

4. Individualizing quality-of-life outcomes reporting: How localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function;Chen;J Clin Oncol.,2009

5. Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity;Karlsdóttir;Int J Radiat Oncol Biol Phys.,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic Body Radiation Therapy (SBRT) in prostate cancer in the presence of hip prosthesis – is it a contraindication? A narrative review;BMC Urology;2024-07-26

2. Feasibility and safety of definite volumetric modulated arc therapy with simultaneous integrated boost to the dominant intraprostatic lesion in patients with unfavorable intermediate to high-risk prostate cancer;Reports of Practical Oncology and Radiotherapy;2022-05-19

3. Stereotactic Radiation Therapy versus Brachytherapy: Relative Strengths of Two Highly Efficient Options for the Treatment of Localized Prostate Cancer;Cancers;2022-04-29

4. Ultrahypofractionated Radiotherapy for Localised Prostate Cancer: How Far Can We Go?;Clinical Oncology;2021-12

5. Radiothérapie en hypofractionnement extrême appliquée au traitement du cancer localisé de la prostate : résultats, limites et perspectives;Cancer/Radiothérapie;2021-10